Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SOX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC100505666 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CLDN19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFAP61 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUOX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102723648 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCLN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFTPB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLP1R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00644 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
COPB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MBD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LSG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DSCR10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNTN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LARP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IDUA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on